-
listening skills and discretion Curiosity and the ability to seek out relevant information Ability to integrate into a team and work collaboratively Scientific integrity and rigour Specific Requirements
-
details in https://umr-right.com ). Summary of the scientific project: The maintenance of T cell effector functions in vivo are critical for the success of cancer immunotherapies including Immune checkpoint
-
completion. This position offers a remarkable opportunity for personal and professional growth in a cutting-edge research environment. Strategy of the host laboratory: The teams of the INCIT unit U1302 (https
-
research program aligned with the strategic priorities of the research center. Candidates should present a strong publication record, the ability to secure competitive funding, and a clear vision for
-
associations, expectant parents, practitioners, and public health policymakers. The candidate must demonstrate their ability to apply for and obtain competitive fundings (ANR, ERC, etc.). Open Science: This
-
of the neoplasms. The integration of synergistic areas of expertise will improve our ability to conduct tailored therapies against resistance and relapse. Summary of the scientific project: The “Chaire INSERM” will
-
group leader in the GAD team. So the candidate should demonstrate ability to supervise Ph.D students, post-doctoral fellow and technical support staff. She/he should have the capacity to obtain
-
clinical transfer. Selection of candidates: It is expected the recruited researcher to become rapidly a group leader in the GAD team. So the candidate should demonstrate ability to supervise Ph.D students
-
ability to supervise Ph.D students, post-doctoral fellow and technical support staff. She/he should have the capacity to obtain competitive funding to manage her/his group. Successful candidates are chosen
-
the GAD team. So the candidate should demonstrate ability to supervise Ph.D students, post-doctoral fellow and technical support staff. She/he should have the capacity to obtain competitive funding